Skip to content

Buying a Pharmacy

Buying a Pharmacy in the UK: The Complete Checklist

11 November 2026 · 9 min read

Get in touch

When a pharmacy comes up for sale, it's natural to look at the shop, the location and the headline turnover first. They're the wrong place to start. What you're buying is the NHS pharmaceutical contract: the right to dispense NHS prescriptions and be paid for them under the Drug Tariff. Without it, the premises are a retail unit. This checklist takes a first purchase, or a second store, through the regulated, financial and structural steps in the order they come up.

The NHS contract rules here are England's, under the Community Pharmacy Contractual Framework (CPCF). Scotland, Wales and Northern Ireland run their own contractual frameworks, so check the local one if the pharmacy's there.

The short answer: the NHS contract is the asset and market entry is regulated

A community pharmacy's income is reimbursement plus remuneration under the Community Pharmacy Contractual Framework, not shop takings, so the value follows the contract. Under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, opening, relocating or buying a pharmacy goes through a regulated process. A change of ownership doesn't carry the contract across by itself: you have to meet the Regulations and the registration requirements before dispensing carries on under you. That's what separates buying a pharmacy from buying an ordinary shop.

What you are actually buying: the contract, item volume and goodwill

  • The NHS contract. The right to dispense NHS prescriptions and be reimbursed by NHSBSA.
  • Item volume. The prescription items dispensed each month drive dispensing income and, in turn, the goodwill. A premium buys a contracted, recurring income measured in items per month.
  • Goodwill. It sits on top of the tangible assets and comes almost entirely from the contract and the item volume. What pharmacy goodwill is worth has its own guide; below is what it means for tax and due diligence when you buy.

Shop fittings, dispensary robots, refrigeration and signage are a small part of the price next to the goodwill, so don't let them drive your view of what the pharmacy's worth.

Regulated market entry: the NHS (Pharmaceutical and LPS) Regulations 2013

Each local health and wellbeing board assesses its area's pharmaceutical needs (the pharmaceutical needs assessment), and NHS England decides applications against it. For a buyer, that means:

  • A new pharmacy can't open just anywhere: it has to fit a market-entry category (a need the assessment identifies, say, or distance selling), or be an existing pharmacy changing hands.
  • On a change of ownership you apply to NHS England to join the pharmaceutical list and meet regulation 26 (in short, the same services with no break in them). The seller's contract doesn't pass to you on completion.
  • Relocating after you buy is a separate application, and approval isn't guaranteed.

The legal side sits with a specialist healthcare solicitor. On the accounting side, build the approval into the timetable and don't count on NHS income until the change is registered: a late approval pushes back your first FP34 advance, and that's a working-capital cost to model.

GPhC registration and the superintendent pharmacist requirement

Who can own a pharmacy is set by the Medicines Act 1968: a pharmacist (in a partnership, every partner has to be one, or in Scotland at least one), or a company that has a superintendent pharmacist (s69, s71). So if you're not a pharmacist, you buy through a company. Pharmacy premises in Great Britain are entered in Part 3 of the register kept by the General Pharmaceutical Council (GPhC). A new entry needs the applicant to be lawfully running a retail pharmacy business there, or about to start (ss74A, 74B), and it lasts a year before it's renewed.

The superintendent has to be a pharmacist and a senior manager with the authority to decide how the business sells and supplies medicines (s71(6)). We deal with that as an ownership point and stop there; the professional side sits with the GPhC, and your solicitor handles the registration steps. In practice, have the superintendent confirmed before or at completion (if the selling owner was the superintendent and is leaving, a gap in cover is a regulatory problem), and put the premises entry on the completion checklist, not the post-completion tidy-up.

The first structuring decision: share purchase versus asset purchase

Settle the structure before due diligence goes deep, and certainly before heads of terms. Buy the shares and you take the company with its whole history, liabilities included; the NHS contract stays in the company, and you pay 0.5% stamp duty on the share price. Buy the assets and you take only what the agreement lists, but NHS England has to approve your change of ownership application before you replace the seller on the pharmaceutical list, and any property in the deal pays SDLT (Land Transaction Tax in Wales, LBTT in Scotland), never the goodwill.

Our guide to share vs asset purchase: pharmacy acquisition structuring sets the two routes side by side, goodwill relief and the GPhC steps included, with worked tax figures.

Goodwill in the price and why it dominates

Goodwill in a pharmacy isn't like goodwill in a café or a solicitors' practice. It comes almost entirely from the NHS contract and monthly item volume, so you're paying for an NHSBSA-reimbursed dispensing income with barriers to entry written into statute.

Two tax points matter at this stage. First, a company that buys a business on or after 1 April 2019 gets corporation tax relief on the goodwill only at a fixed 6.5% a year, only if qualifying IP assets (a patent, registered design or copyright, for example) come with it, and only on goodwill up to six times the IP's cost. Without them there's no relief while the company holds the goodwill, so don't plan on writing it off against profits. Second, there's no multiple here: goodwill trades on adjusted EBITDA multiples and pence-per-item benchmarks, and the market figure for your pharmacy comes from a specialist broker. Pharmacy goodwill: what it is and what drives its value goes through both methods.

Due diligence: the items a pharmacy buyer cannot skip

Start with the general checks (accounts, lease, staff, litigation). A pharmacy then has four layers a standard checklist won't reach. The financial due diligence guide has the full document list and the red flags; this is the short version.

FP34 and NHSBSA payment history

Each month's prescriptions are declared to NHSBSA on the FP34C by the 5th of the next month. NHSBSA pays a 100% estimated advance around the 10th and settles the difference two months after submission (Drug Tariff Part I Clause 5C, England; see the NHSBSA submission and payment process). Ask for:

  • At least 24 months of FP34 submissions and the matching NHSBSA payment remittances, reconciled to the accounts.
  • The item volume trend: growing, flat or falling, and why.
  • A plan for the payments either side of completion. The seller's last advance and reconciliations land after you take over, and a negative reconciliation comes out of the next advance, so the completion accounts have to say who keeps which payment and who bears a recovery.

Drug Tariff and Category M margin story

Each item is paid at the Drug Tariff price listed for the month it's dispensed. DHSC resets Category M prices every quarter from suppliers' price information, and when the sector has earned more margin than the contract funds, later quarters' prices are set lower to recoup it (the clawback). For 2026/27 up to £239 million of past net over-delivery is written off and nothing further is being recovered, but the quarterly resets carry on. So check:

  • Whether the gross margin has held across the last eight quarters, or rests on a few quarters when Category M prices ran high.
  • How much of the dispensing is Category M generics, and what the next quarter's prices do to the forward margin.

VAT mix

NHS-dispensed prescription drugs are zero-rated and over-the-counter medicines are standard-rated, so the pharmacy is VAT-mixed. Zero-rated dispensing counts towards the £90,000 registration threshold, so an NHS pharmacy over it has to be registered unless HMRC has granted exemption from registration. Check:

  • That the retail scheme suits the actual sales mix and the Retail Chemist Adjustment is made where the scheme needs it (VAT Notice 727 section 8; how pharmacy VAT works explains the adjustment).
  • Any VAT assessments or disputes in the last four years. In a share deal, a mis-applied scheme becomes your liability.
  • On an asset deal, that every transfer of a going concern condition in VAT Notice 700/9 holds, so no VAT goes on the price. The due diligence guide lists them, including the option to tax on the premises.

Lease, premises and TUPE

  • Lease: the term, rent review, break clauses and, above all, whether the landlord's consent is needed for an assignment or share sale. A lease that can't be assigned kills an asset deal.
  • TUPE: on an asset deal, the staff transfer to you under the Transfer of Undertakings (Protection of Employment) Regulations 2006 (on a share deal their employer, the company, doesn't change). Review contracts, pay, holiday accrual and any grievances or tribunal claims before agreeing the price.
  • Pharmacy First and service income: confirm which advanced and enhanced services the pharmacy provides and whether they transfer or need a new application. Service income is its own revenue line (each Pharmacy First clinical pathway consultation pays £17 in 2026/27), and a gap in provision hits day-one income.

Funding and affordability: what finance-ready means

A pharmacy loan is lent against the contract, not the building, so a lender wants the contract, the item volume trend and the net NHS income, not just the balance sheet. Finance-ready means two to three years of the target's accounts in a form lenders recognise, a working-capital model that covers the stock and wages you pay before the first NHSBSA advance and how Category M margin has moved quarter by quarter, and a clear VAT position.

The pharmacy purchase affordability calculator estimates the loan, the monthly repayment, the post-tax cash cover (corporation tax worked on profit after the first year's loan interest) and the stamp duty or SDLT. It's a planning estimate, not an offer-ready figure, so use it to frame the lender conversation and then speak to us. If it's your first pharmacy, first-time pharmacy buyer finance goes further.

Add the purchase price, deposit, loan terms and projected profit to see the monthly repayment, the post-tax cash cover and the stamp duty or SDLT on a share deal against an asset deal.

Calculator

Pharmacy Purchase Affordability Calculator

Enter the purchase price, deposit, loan terms and projected pharmacy profit to see your estimated loan repayments, how well trading cash flow covers the debt, and the acquisition tax cost for a share deal versus an asset deal. Every figure already in the boxes is an example, so replace it with your own; the result on your deal depends on how it's structured.

£

The agreed headline price for the pharmacy. Enter the actual figure from your heads of terms.

£

The amount you are putting in from your own funds. The rest is assumed to be financed by a commercial loan.

The term your lender offers. Shorter terms mean higher repayments but less total interest.

The rate quoted by the lender. The rate you are offered depends on lender, term and loan-to-value.

£

The part of the price that buys land or buildings: a freehold, or what you pay for a lease. Leave at 0 if no property is being bought. SDLT is charged on this figure only, never on goodwill or the NHS contract.

£

Only if you're taking a new lease of the premises. SDLT is due on the rent's net present value at 1% from £150,001 to £5 million and 2% above. HMRC's SDLT calculator works the figure out from the rent and the term.

£

The adjusted EBITDA or trading profit you expect after your salary, before loan interest and tax. The tool takes the first year's interest off before working out corporation tax.

Your result

Your answer's ready. Press below to see it.

The end-to-end checklist

Here's the whole purchase in stages, with the accountant's part in each and what goes wrong if it's skipped.

Stage What it covers Accountant's role Risk if skipped
1. Identify the right target Listing, item volume, contract type, location, competitors Screen item volume and income against affordability; flag reliance on one GP surgery Overpaying for falling volume or a contract under threat
2. Settle the structure Share or asset; personal or company buyer; goodwill; SDLT or stamp duty Model the tax cost of each structure, goodwill relief included Wrong structure locked in at heads of terms
3. Heads of terms Price, structure, exclusivity, conditions including NHS approval Confirm the price split between goodwill, fixtures and property; flag deferred consideration timing Price split agreed verbally, then disputed at completion
4. NHS and GPhC steps Change of ownership application (asset deal) or notice of new directors (share deal); premises entry; superintendent (companies) Model the cost of the approval timeline; plan when the first FP34 declaration and advance fall A gap in NHS registration means a gap in dispensing income
5. Financial due diligence 24+ months of FP34 history; Category M margin; VAT scheme and partial exemption Reconcile NHSBSA remittances to the accounts; check the scheme and the Retail Chemist Adjustment Paying for margin that isn't there; inheriting VAT liabilities or a negative reconciliation
6. Legal due diligence Lease and assignment; TUPE; litigation; company history (share deal) Review the TUPE staff cost schedule; check leasehold improvements are capitalised correctly Lease can't be assigned; hidden employment or company tax liabilities
7. Finance and funding Lender pack; working-capital model; day-one VAT registration Prepare finance-ready accounts and the cash model Lender declines; cash runs short before the first NHSBSA advance
8. Completion accounts Locked box or completion accounts; NHSBSA payments either side; stock Prepare or review the completion accounts; agree who keeps which NHSBSA payment Net asset value disputed; settlement delayed
9. Day-one accounting New books; VAT retail scheme; FP34 calendar; payroll in the new entity Set the retail scheme for the real sales mix; set the FP34 calendar; move payroll Mis-stated first months; VAT overpaid from day one
10. After completion First remittance check; Drug Tariff movement; Pharmacy First income Reconcile the first remittance to item volume; start monthly margin variance analysis Quarterly Category M changes missed until year end; cash shortfall

Want this checked against your specific situation?

Leave your details and a one-line summary. One of our specialists will come back to you, with no obligation.

We'll only use your details to respond to your enquiry. We don't pass them to any other firm. See our Privacy Policy.

Getting deal support

A general business review covers the mechanics. Specialist help earns its keep on the pharmacy layer: due diligence on the NHSBSA remittances, margin and VAT scheme, the share or asset structure, and day-one accounting, so your first months aren't spent fixing inherited problems. The buying a pharmacy hub brings the buying guides together, the purchase affordability calculator frames your numbers before a first call, and when you're ready to talk about a deal, get in touch. We reply within 24 hours.

Frequently asked questions

The NHS pharmaceutical contract and the dispensing income it brings in, not the shop or its fittings. The contract is governed by the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 and doesn't transfer automatically on a change of ownership.

Not if you buy through a company. The Medicines Act 1968 (s69) lets a pharmacist run a retail pharmacy business (in a partnership, every partner has to be one, or in Scotland at least one), or a company that has a superintendent pharmacist (s71). So a non-pharmacist buys through a company. The premises also need an entry in the GPhC register.

It's the pharmacist a company needs before it can lawfully run a retail pharmacy business (Medicines Act 1968 s71). The Act says the superintendent has to be a pharmacist and a senior manager with the authority to make decisions on how the business sells and supplies medicines (s71(6)). We deal with it as an ownership requirement only, not the professional side of the role.

It can be either, and choosing is the first structuring decision. A share deal pays 0.5% stamp duty on the share value (until the Securities Transfer Tax, announced for late 2027) and inherits the company's history, liabilities included. An asset deal pays SDLT on any property at non-residential rates up to 5% and gives you a clean start.

There's no single headline price. It's driven mainly by the goodwill, which reflects the NHS contract and monthly item volume, and by any property interest, and valuers work from adjusted EBITDA multiples and pence-per-item benchmarks. On top come transaction tax, professional fees and the working capital you need before the first NHS advance. The purchase affordability calculator models your own scenario.

Not on an asset purchase: NHS England has to approve your application to replace the seller on the pharmaceutical list, under regulation 26 of the NHS (Pharmaceutical and LPS) Regulations 2013. Buy the company instead and its listing stays where it is, though the company still owes NHS England notice of new directors or a new superintendent.

At minimum: review the NHSBSA FP34 payment history and item volumes, understand the Category M margin story and Drug Tariff position, map the VAT mix (zero-rated dispensing against standard-rated over-the-counter sales), check the lease and assignment rights, and assess staff and TUPE obligations.

Related reading

Need help with your pharmacy finances?

Tell us about your situation and we will come back within 24 hours.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)